Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1972 1
1973 1
1975 2
1976 1
1977 1
1981 1
1983 1
1984 2
1985 1
1986 1
1987 1
1988 1
1991 1
1997 1
1998 3
2000 5
2001 7
2002 4
2003 4
2004 3
2005 4
2006 2
2007 8
2008 9
2009 8
2010 7
2011 4
2012 5
2013 6
2014 4
2015 6
2016 2
2017 5
2018 5
2019 9
2020 6
2021 9
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

131 results
Results by year
Filters applied: . Clear all
Page 1
Withdrawal: The role of ERp44 in maturation of serotonin transporter protein.
Freyaldenhoven S, Li Y, Kocabas AM, Ziu E, Ucer S, Ramanagoudr-Bhojappa R, Miller GP, Kilic F. Freyaldenhoven S, et al. Among authors: miller gp. J Biol Chem. 2019 Jan 4;294(1):70. doi: 10.1074/jbc.W118.007073. J Biol Chem. 2019. PMID: 30610126 Free PMC article. No abstract available.
2,5-Dichloro-thio-phene 1,1-dioxide.
Briggs JB, Jia W, Jazdzyk MD, Miller GP. Briggs JB, et al. Among authors: miller gp. Acta Crystallogr Sect E Struct Rep Online. 2009 Nov 28;65(Pt 12):o3258. doi: 10.1107/S1600536809050776. Acta Crystallogr Sect E Struct Rep Online. 2009. PMID: 21578954 Free PMC article.
Impacts of diphenylamine NSAID halogenation on bioactivation risks.
Schleiff MA, Payakachat S, Schleiff BM, Swamidass SJ, Boysen G, Miller GP. Schleiff MA, et al. Among authors: miller gp. Toxicology. 2021 Jun 30;458:152832. doi: 10.1016/j.tox.2021.152832. Epub 2021 Jun 6. Toxicology. 2021. PMID: 34107285
Biotransformation and bioactivation reactions - 2018 literature highlights.
Khojasteh SC, Bumpus NN, Driscoll JP, Miller GP, Mitra K, Rietjens IMCM, Zhang D. Khojasteh SC, et al. Among authors: miller gp. Drug Metab Rev. 2019 May;51(2):121-161. doi: 10.1080/03602532.2019.1615937. Epub 2019 Aug 6. Drug Metab Rev. 2019. PMID: 31170851 Review.
Rolapitant Is a Reversible Inhibitor of CYP2D6.
Glass SM, Leddy SM, Orwin MC, Miller GP, Furge KA, Furge LL. Glass SM, et al. Among authors: miller gp. Drug Metab Dispos. 2019 Jun;47(6):567-573. doi: 10.1124/dmd.118.085928. Epub 2019 Apr 5. Drug Metab Dispos. 2019. PMID: 30952677 Free PMC article.
Novel advances in biotransformation and bioactivation research - 2020 year in review.
Khojasteh SC, Argikar UA, Driscoll JP, Heck CJS, King L, Jackson KD, Jian W, Kalgutkar AS, Miller GP, Kramlinger V, Rietjens IMCM, Teitelbaum AM, Wang K, Wei C. Khojasteh SC, et al. Among authors: miller gp. Drug Metab Rev. 2021 Aug;53(3):384-433. doi: 10.1080/03602532.2021.1916028. Epub 2021 Jun 24. Drug Metab Rev. 2021. PMID: 33910427
Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam.
Barnette DA, Schleiff MA, Osborn LR, Flynn N, Matlock M, Swamidass SJ, Miller GP. Barnette DA, et al. Among authors: miller gp. Toxicology. 2020 Jul;440:152478. doi: 10.1016/j.tox.2020.152478. Epub 2020 May 11. Toxicology. 2020. PMID: 32437779 Free PMC article.
131 results